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ABSTRACT 
An intriguing hypothesis that latrunculin A, a well-known natural product, might have undergone 
transformation into the unprecedented thiopyrone CTP-431 upon long-term storage in methanol is 
advanced. Thus opening of the hemiacetal of latrunculin A, followed by E1CB elimination, and 
dehydration would give a polyene that could undergo intramolecular Diels-Alder reaction, followed 
by methanolysis of the thiazolidinone ring and ring closure by intramolecular thiol addition to an 
enone. Experimental evidence that the novel thiazolidinone to thiopyrone rearrangement can occur 
is presented. 
 
 
The marine sponge Cacospongia mycofijiensis, found in the ocean surrounding Fiji, is a source of 
several polyketide natural products with interesting biological properties,1 including the tubulin 
binding macrolide fijianolide B (also known as laulimalide),2,3 the HIF1 signal inhibitor 
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mycothiazole,4,5 and the macrolide latrunculins (Figure 1).6 The thiazolidinone-containing 
latruculins are of mixed polyketide synthesis (PKS) and non-ribosomal peptide synthesis (NRPS) 
origin, and latrunculin A 1 disrupts microfilament assembly to such an extent that it is the most 
widely used chemical tool to study actin binding.  
 
 
Figure 1. Marine natural products from the sponge Cacospongia mycofijiensis. 
 
In the course of their seminal studies on the biology and chemistry of metabolites extracted from C. 
mycofijiensis, in 2008 the Crews laboratory reported the “unexpected” isolation of a new 
compound, CTP-431 7, containing an unprecedented thiopyrone ring fused to a hydrindane, the 
structure being confirmed by X-ray crystallographic analysis.1 Although Crews et al. proposed a 
logical biogenesis involving a PKS-NRPS derived linear precursor that could cyclize to both 
latrunculin A and CTP-431, our attention was caught by the unusual provenance of CTP-431. It was 
isolated from a crude sponge extract that had been stored in methanol at 4 °C for 19 years, and in 
which the expected compound latrunculin A was found to be entirely absent. This absence, coupled 
with the similarity in carbon backbones of latrunculin A and CTP-431 and the complete absence of 
other thiopyrones from the natural world, invite the intriguing hypothesis that latrunculin A might 
have undergone transformation into CTP-431 upon long-term storage in methanol. The likely 
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product of methanolysis of the thiazolidinone ring would be a methyl carbamate resembling the one 
found in CTP-431, providing support for our hypothesis. 
 
We therefore propose that a possible mechanism (Scheme 1) for this interconversion would proceed 
from the hemiacetal of latrunculin A 1 to its open-chain isomer 2, followed by E1CB elimination of 
the lactone and subsequent dehydration of alcohol 3 to give polyene 4; the structures of congeners 
such as latrunculeic acid (Figure 1) provide some evidence that this carboxylate elimination can 
occur readily.7 Intramolecular Diels-Alder (IMDA) reaction of 4, followed by isomerization of the 
double bond to restore conjugation, would give the hydrindane 5. Methanolysis of the 
thiazolidinone would lead to rapid 6-endo-trig conjugate addition of the thiol to give thiopyranone 
6, and autoxidation of the tricyclic system would give the final product, CTP-431 7 (Scheme 1).  
Scheme 1. Proposed conversion of latrunculin A into CTP-131. 
 
The fascinating possibility of such an extended sequence of spontaneous reactions occurring over a 
prolonged period prompted us to embark upon a model study to investigate the feasibility of such a 
transformation. There are two pivotal steps in the proposed sequence of events outlined in Scheme 
1, the IMDA reaction of triene 4 to give, after double bond isomerization, hydrindane 5, and the 
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subsequent methanolysis of the thiazolidinone ring followed by reclosure by intramolecular thiol 
addition to the enone (5 to 6, Scheme 1). Of these, the former is well precedented with several 
examples of IMDA reactions of trienes leading to hydrindane derivatives, including many with a 
similar substitution pattern on diene and dienophile fragments,8-12 although the conditions usually 
required to effect IMDA reactions vary from those used to store the natural sample. Nevertheless, 
we took the view that such an IMDA step was feasible, and thus our experimental focus was on the 
key thiazolidinone ring-opening step.  
 
The ring opening of thiazolidinones is reported to occur under aqueous alkaline conditions, 
followed by decarboxylation to give cysteamine derivatives.13,14 The present case necessitates a 
methanolysis initiated ring-rearrangement reaction of the thiazolidinone to a 
tetrahydrothiopyranone, and therefore as a model for the CTP-431 system, we selected the 
cyclohexenyl ketone 12. The synthesis began with the cyclization of cysteine ethyl ester 8 using 
CDI, followed by protection of the nitrogen with a 4-methoxybenzyl (PMB) group to give the 
thiazolidinone 9. Conversion into the cyclohexenyl ketone 11 was effected via the known Weinreb 
amide 10,15 using 1-bromocyclohexene and t-BuLi. The PMB group was removed oxidatively using 
cerium(IV) ammonium nitrate (CAN) in aqueous acetonitrile to give the thiazolidinone ring-
rearrangement precursor 12 (Scheme 2). The structures of both thiazolidinones 11 and 12 were 
confirmed by X-ray crystallography (Figure 2). 
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Scheme 2. Synthesis of model thiazolidinone enone 12. 
 
 
 
Figure 2. X-Ray crystal structures of thiazolidinones 11 (CCDC 1840513) and 12 (CCDC 
1840514). 
 
According to our initial hypothesis, the ring rearrangement requires the attack of methanol on the 
thiazolidinone carbonyl, followed by elimination and conjugate addition of the thiol to the enone 
functionality via a 6-endo-trig process, a known but rare process.16-18 Although the ring opening of 
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thiazolidinones is known under aqueous conditions (vide supra), alcoholysis reactions are rare. 
Mellor et al. have reported the conversion of 4-vinyl thiazolidinones to methyl carbamates using 
potassium hydroxide in methanol,19 but these conditions gave no identifiable products in the case of 
our cyclohexenyl derivative 12. The use of sodium or potassium methoxide in methanol at various 
temperatures similarly led only to decomposition of the starting material. With basic conditions 
having failed and Brønsted acids such as TsOH giving no reaction at all, a variety of metal salts 
were employed as Lewis acid catalysts (see Table S1, Supporting Information), in the hope that 
coordination to the sulfur atom might increase the reactivity of the thiazolidinone towards methanol. 
Silver(I) acetate, lead(II) chloride, gold(I) chloride, zinc(II) chloride and scandium(III) triflate all 
gave no reaction, while other silver salts such as AgBF4 and AgPF6 resulted in decomposition of the 
thiazolidinone 12. An attempt to use mercury(II) acetate in methanol at room temperature gave no 
isolable product, but when these conditions were followed by addition of excess 1,3-propanedithiol 
to sequester the mercury away from the thiol, the products 13, 14 and 15 were isolated in 7%, 12% 
and 51% yield respectively (Scheme 3). While we were pleased to identify the desired product of 
the thiol conjugate addition reaction 13, it was in a disappointing yield, with most of the material 
converted to the side-products 14 and 15. The stereochemistry of 14 was suggested by NOESY 
spectroscopy, but is inconsequential since compound 14 represents a dead end in our proposed 
reaction pathway (Scheme 4). Attempts to improve on this result using other mercury sources 
proved fruitless, but the use of a less polar solvent mixture – 19:1 toluene:methanol – disfavoured 
the hemiacetal formation, giving none of the side-product 14 and a slightly improved yield (12%) of 
the desired product 13. Applying the1,3-propanedithiol work-up to reactions with other metal 
catalysts did not improve the outcomes of those reactions, and attempts to convert the cyclic 
carbamate 15 into the methyl carbamate 13 under acidic or basic conditions were unsuccessful.  
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Scheme 3. Ring opening rearrangement of thiazolidinone 12 into thiopyranone derivatives.  
 
The formation of the major product 15, identified by X-ray crystallography (Figure 3), initially 
suggested the possibility that the thiazolidinone had undergone attack not by methanol, but by the 
hemiacetal of the pendant ketone. However, the fact that conjugate addition had also occurred 
indicated that the thiol must have been liberated while the enone functionality was still intact, 
leading us to propose instead that an elimination reaction occurs first, producing a thiol and an 
isocyanate 16 (Scheme 4); the thiol is rapidly trapped by the enone, and the ketone oxygen is well 
placed to undergo reaction with the isocyanate as its hemiacetal. Further support for this mechanism 
came from the failed ring-rearrangement of the PMB-protected thiazolidinone 11 under the same 
reaction conditions. When the hydrolysis was carried out under aqueous conditions, followed by 
treatment of the product with an excess of methyl chloroformate, the intermediate thiol 16 was 
trapped, the isocyanate intercepted by the ketone oxygen in its enol form to give, after further 
reaction at nitrogen with methyl chloroformate, the adduct 17 (Scheme 5), the structure of which 
was also confirmed by X-ray crystallography (Figure 3). 
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Scheme 4. Proposed mechanism for ring opening rearrangement of thiazolidinone 12 into 
thiopyranone derivatives. 
 
 
Scheme 5. Interception of thiol intermediate 16 with methyl chloroformate. 
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Figure 3. X-Ray crystal structures of oxazolidinones 15 (CCDC 1840516) and 17 (CCDC 
1840515). 
 
In summary, we have investigated some of the key steps required for the conversion of latrunculin 
A 1 to its congener CTP-431 7 and demonstrated experimentally that the critical ring rearrangement 
sequence of the thiazolidinone to the corresponding tetrahydrothiopyranone is viable. Although the 
conditions required for both this key step and the proposed IMDA reaction vary significantly from 
those used to store the natural sample, given the crude nature of the sponge extract it is impossible 
to discount the possibility of some form of catalysis in the latter case. Hence we believe that these 
are feasible steps along the pathway from latrunculin A to CTP-431, and we hope that this will 
stimulate further work on the origins of this remarkable natural, or possibly unnatural, product. 
 
EXPERIMENTAL SECTION 
General experimental details 
Commercially available reagents were used throughout without purification unless otherwise stated. 
All anhydrous solvents were used as supplied, except tetrahydrofuran and dichloromethane that 
were freshly distilled according to standard procedures. Reactions were routinely carried out under 
an argon atmosphere unless otherwise stated, and all glassware was flame-dried before use. Light 
petroleum refers to the fraction with bp 40–60 °C. Ether refers to diethyl ether. 
10 
 
Analytical thin layer chromatography was carried out on aluminum-backed plates coated with silica 
gel, and visualized under UV light at 254 and/or 360 nm and/or by chemical staining. Flash 
chromatography was carried out using silica gel, with the eluent specified. 
 
Infrared spectra were recorded using an FT-IR spectrometer over the range 4000–600 cm−1. NMR 
spectra were recorded at 400 or 500 MHz (1H frequency, 100 or 125 MHz 13C frequency). 
Chemical shifts are quoted in parts per million (ppm), and are referenced to residual H in the 
deuterated solvent as the internal standard. Coupling constants, J, are quoted in Hz. In the 13C 
NMR spectra, signals corresponding to CH, CH2, or CH3 groups are assigned from the DEPT 
spectra. Mass spectra were recorded on a time-of-flight (TOF) mass spectrometer using electrospray 
ionization (ESI). 
 
Ethyl (R)-2-oxothiazolidine-4-carboxylate 
 
1,1-Carbonyldiimidazole (8.11 g, 50 mmol) was added in portions over 5 min to a stirred 
suspension of (L)-cysteine ethyl ester hydrochloride (9.28 g, 50 mmol) in THF (150 mL). The 
mixture was stirred at room temperature for 16 h, filtered through a pad of Celite® and washed with 
THF (150 mL). The filtrate was concentrated in vacuo and purified by column chromatography 
eluting with light petroleum and ethyl acetate (1:1) to give the title compound as a colorless oil 
(6.39 g, 87%); [α] !"!  -58.1 (c 3.14, CHCl3) (lit.,20 [α] !"!  -51.8 (c 3.14, CHCl3) ; HRMS (ESI-TOF) m/z: 
[M+Na]+ Calcd for C6H9NO3SNa 198.0195; found 198.0202; νmax (thin film)/cm-1 3299 (br), 2984, 2940, 2907, 
2873, 1742, 1686, 1206, 1025; δH (400 MHz; CDCl3) 6.31 (1 H, br s), 4.43 (1 H, ddd, J 8.0, 5.2, 0.8), 4.28 (2 H, 
q, J 6.8), 3.71 (1 H, dd, J 11.2, 8.0), 3.63 (1 H, dd, J 11.2, 5.2), 1.32 (3 H, t, J 6.8); δC (100 MHz, CDCl3) 174.4, 
169.8, 62.4 (CH2), 55.9 (CH), 31.7 (CH2), 14.1 (Me). 
 
11 
Ethyl (R)-3-(4-methoxybenzyl)-2-oxothiazolidine-4-carboxylate 9 
 
Potassium carbonate (5.52 g, 40 mmol), sodium iodide (0.45 g, 3 mmol) and 4-methoxybenzyl 
chloride (2.35 g, 15 mmol) were added sequentially to a stirred solution of the above ester (1.75 g, 
10 mmol) in DMF (25 mL). The resulting mixture was stirred at room temperature for 16 h, diluted 
with water (75 mL) and extracted with ethyl acetate (3 x 20 mL). The combined organic phases 
were washed with water (30 mL) and brine (30 mL), dried (Na2SO4), filtered and concentrated. 
Column chromatography eluting with light petroleum and ethyl acetate (4:1 then 3:1) gave the title 
compound as a colorless oil (2.94 g, 99%); [α] !"!  -66.8 (c 1.30, EtOH) (lit.,20 [α] !"!  -96.7 (c 1.3, EtOH) ; 
HRMS (ESI-TOF) m/z: [M+Na]+ Calcd for C14H17NO4SNa 318.0770; found 318.0757; δH (400 MHz; CDCl3) 
7.17 (2 H, d, J 8.6), 6.87 (2 H, d, J 8.6), 5.09 (1 H, d, J 14.8), 4.25 (2 H, q, J 7.0), 4.13 (1 H, dd, J 8.6, 3.2), 4.00 
(1 H, d, J 14.8), 3.81 (3 H, s), 3.48 (1 H, dd, J 11.4, 8.6), 3.34 (1 H, dd, J 11.4, 3.2), 1.31 (3 H, t, J 7.0); δC (100 
MHz, CDCl3) 171.5, 169.9, 159.4, 129.8 (CH), 127.6, 114.2 (CH), 62.2 (CH2), 59.3 (CH), 55.3 (Me), 47.3 (CH2), 
29.0 (CH2), 14.2 (Me).  
 
(R)-N-Methoxy-3-(4-methoxybenzyl)-N-methyl-2-oxothiazolidine-4-carboxamide 10 
 
A solution of isopropylmagnesium chloride (0.99 M in THF; 12.2 mL, 12.0 mmol) was added dropwise to a 
suspension of N,O-dimethylhydroxylamine hydrochloride (0.585 g, 6.0 mmol) and ester 9 (1.18 g, 4.0 mmol) in 
THF (40 mL) at -20 °C. The resulting mixture was stirred at -20 °C for 30 min, then quenched with saturated 
ammonium chloride solution (10 mL) followed by ethyl acetate (20 mL) and water (50 mL). The aqueous phase 
was extracted with ethyl acetate (4 x 20 mL), and the combined organic phases were washed with brine (25 mL) 
12 
then dried (MgSO4), filtered and concentrated. Column chromatography eluting with light petroleum and ethyl 
acetate (1:1) gave the title compound as a colorless oil (1.23 g, 99%); α !"!  -63.8 (c 1.00, CH2Cl2); HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C14H19N2O4S 311.1060; found 311.1055; νmax (thin film)/cm-1 3002, 2939, 
1682, 1612, 1514, 1259, 1176, 732; δH (400 MHz; CDCl3) 7.16 (2 H, d, J 8.4), 6.86 (2 H, d, J 8.4), 5.13 (1 H, d, J 
14.6), 4.40 (1 H, dd, J 8.6, 4.8), 3.84 (1 H, d, J 14.6), 3.79 (3 H, s), 3.46 (1 H, dd, J 11.2, 8.6), 3.38 (3 H, s), 3.21 
(3 H, s), 3.15 (1 H, dd, J 11.2, 4.8); δC (100 MHz, CDCl3) 172.3, 169.1, 159.4, 130.0 (CH), 127.6, 114.1 (CH), 
61.2 (Me), 57.4 (CH), 55.3 (Me), 46.9 (CH2), 32.5 (Me), 28.0 (CH2). NMR data matches those described in the 
literature.15 
 
(R)-4-(Cyclohex-1-ene-1-carbonyl)-3-(4-methoxybenzyl)thiazolidin-2-one 11 
  
tert-Butyllithium (1.35 M in pentane; 14.8 mL, 20 mmol) was added dropwise to a solution of 1-
bromocyclohexene21 (3.61 g, 22 mmol) in THF (150 mL) at -78 °C. After 15 min at -78 °C, a solution of 
Weinreb amide 10 (3.10 g, 10 mmol) in THF (50 mL) was added. The mixture was stirred at -78 °C for 1 h, 
quenched with saturated ammonium chloride solution (50 mL), warmed to room temperature and extracted with 
ethyl acetate (3 x 50 mL). The combined organic phases were washed with brine (50 mL), dried (MgSO4), 
filtered and concentrated. Column chromatography eluting with light petroleum and ethyl acetate (3:1 then 2:1) 
gave the title compound as a colorless solid (1.85 g, 56%); mp 212-214 °C; α !"!  -13.7 (c 0.45, CHCl3); HRMS 
(ESI-TOF) m/z: [M+Na]+ Calcd for C18H21NO3SNa 354.1134; found 354.1137; νmax (ATR)/cm-1 3002, 2927, 
1733, 1673, 1661; δH (400 MHz; CDCl3) 7.11 (2 H, d, J 8.5), 6.86 (2 H, d, J 8.5), 6.67 (1 H, td, J 4.1, 2.1), 5.12 
(1 H, d, J 14.8), 4.81 (1 H, dd, J 9.2, 4.8), 3.82 (3 H, s), 3.70 (1 H, d, J 14.8), 3.47 (1 H, dd, J 11.2, 9.2), 3.12 (1 
H, dd, J 11.2, 4.8), 2.40-2.13 (4 H, m), 1.70-1.62 (4 H, m); δC (100 MHz, CDCl3) 194.8, 172.1, 159.3, 141.9 
(CH), 137.2, 129.9 (CH), 127.8, 114.2 (CH), 59.2 (CH), 55.2 (Me), 47.1 (CH2), 29.2 (CH2), 26.3 (CH2), 23.3 
(CH2), 21.6 (CH2), 21.3 (CH2).  
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(R)-4-(Cyclohex-1-ene-1-carbonyl)thiazolidin-2-one 12 
  
A solution of ammonium cerium nitrate (5.82 g, 10.62 mmol) in water (18 mL) was added to a 
solution of thiazolidinone 11 in acetonitrile (35 mL). The resulting mixture was stirred at room 
temperature for 20 min, diluted with saturated sodium thiosulfate solution (15 mL) and extracted 
with dichloromethane (3 x 50 mL). The combined organic phases were washed with brine (50 mL), 
dried (MgSO4), filtered and concentrated. Column chromatography eluting with light petroleum and 
ethyl acetate (3:1 then 1:1) gave the title compound as a colorless solid (0.545 g, 73%); mp 166-168 
°C; α !"!  -25.8 (c 0.6, CHCl3); HRMS (ESI-TOF) m/z: [M+Na]+ Calcd for C10H13NO2SNa 234.0559; found 
234.0559; νmax (ATR)/cm-1 3181, 3073, 2931, 2856, 1669, 1653, 1203, 1194; δH (400 MHz; CDCl3) 6.91 (1 H, 
dd, J 3.8, 2.1), 6.12 (1 H, br s), 5.08 (1 H, ddd, J 8.4, 7.1, 0.8), 3.67 (1 H, dd, J 11.1, 8.4), 3.51 (1 H, dd, J 11.1, 
7.1), 2.44-2.13 (4 H, m), 1.76-1.63 (4 H, m); δC (100 MHz, CDCl3) 194.9, 175.5, 142.9 (CH), 136.8, 57.7 (CH), 
32.4 (CH2), 26.3 (CH2), 23.3 (CH2), 21.6 (CH2), 21.3 (CH2). 
 
Ring rearrangement  
Method 1: Mercury(II) acetate (0.382 g, 1.2 mmol) was added to a solution of 11 (0.084 g, 0.4 
mmol) in methanol (8 mL). The resulting suspension was stirred at room temperature for 15 min, 
and then 1,3-propanedithiol (0.361 mL, 3.6 mmol) was added. The suspension was stirred for a 
further 1 h, filtered and concentrated in vacuo. Column chromatography eluting with ethyl acetate 
and light petroleum (1:4) gave compound 13 (0.07 g, 7%) followed by compound 14 (0.012 g, 
12%) followed by compound 15 (0.049 g, 51%).  
 
Method 2: Mercury(II) acetate (0.382 g, 1.2 mmol) was added to a solution of 11 (0.084 g, 0.4 
mmol) in toluene (7.6 mL) and methanol (0.4 mL). The resulting suspension was stirred at room 
14 
temperature for 15 min, and then 1,3-propanedithiol (0.361 mL, 3.6 mmol) was added. The 
suspension was stirred for a further 45 min, filtered and concentrated in vacuo. Column 
chromatography eluting with ethyl acetate and light petroleum (1:4) gave compound 13 (0.012 g, 
12%) followed by compound 15 (0.031 g, 32%);  
 
Methyl ((3R,4aS,8aS)-4-oxooctahydro-2H-thiochromen-3-yl)carbamate 13 
  
Colorless oil; α !"!  8.1 (c 0.2, CHCl3); HRMS (ESI-TOF) m/z: [M+Na]+ Calcd for C11H17NO3SNa 266.0821; 
found 266.0812; νmax (CHCl3)/cm-1 3011, 1711, 1500; δH (400 MHz; CDCl3) 5.99 (1 H, br s), 4.53 (1 H, dt, J 
11.7, 5.6), 3.70 (3 H, s), 3.35 (1 H, dd, J 13.7, 5.6), 3.19-3.14 (2 H, m), 2.89 (1 H, dd, J 13.7, 11.7), 1.89-1.82 (2 
H, m), 2.25 (1 H, dddd, J 13.7, 5.3, 3.4, 2.0), 1.58-1.52 (3 H, m), 1.43-1.34 (2 H, m); δC (100 MHz, CDCl3) 
205.7, 156.2, 60.6 (CH), 52.3 (Me + CH), 46.1 (CH), 32.1 (CH2), 31.0 (CH2), 27.1 (CH2), 26.7 
(CH2), 20.9 (CH2). 
 
(4R,5R)-5-(Cyclohex-1-en-1-yl)-4-(mercaptomethyl)-5-methoxyoxazolidin-2-one 14 
 
Colorless oil; α !"!  -6.1 (c 0.2, CHCl3); HRMS (ESI-TOF) m/z: [M+Na]+ Calcd for C11H17NO3SNa 266.0821; 
found 266.0820; νmax (CHCl3)/cm-1 3008, 2929, 1768, 1291; δH (400 MHz; CDCl3) 6.13 (1 H, dt, J 3.9, 2.1), 5.66 
(1 H, br s), 3.70 (1 H, ddd, J 10.4, 3.6, 0.9), 3.29 (3 H, s), 2.87 (1 H, ddd, J 14.1, 7.3, 3.6), 2.75 (1 H, dt, J 14.1, 
10.4), 2.19-2.09 (2 H, m), 2.02-1.85 (2 H, m), 1.75-1.60 (4 H, m), 1.45 (1 H, dd, J 10.4, 7.3); δC (100 MHz, 
CDCl3) 156.2, 132.5, 127.8 (CH), 106.7, 63.7 (CH), 51.1 (Me), 25.3 (CH2), 24.7 (CH2), 23.5 (CH2), 
22.3 (CH2), 21.9 (CH2). 
 
S
O
H
HNH
O
MeO
15 
(3aR,5aS,9aS,9bR)-9b-Methoxyoctahydro-4H-thiochromeno[3,4-d]oxazol-2(3H)-one 15 
 
Colorless solid, mp 81-83 °C; α !"!  21.5 (c 1.0, CHCl3); HRMS (ESI-TOF) m/z: [M+Na]+ Calcd for 
C11H17NO3SNa 266.0821; found 266.0819; νmax (CHCl3)/cm-1 3261, 3006, 2939, 1753, 1447, 1375; δH (400 
MHz; CDCl3) 5.43 (1 H, br s), 3.77 (1 H, dd, J 6.4, 4.8, 1.0), 3.44-3.40 (1 H, m), 3.41 (3 H, s), 3.14 (1 H, dd, J 
14.3, 4.8), 2.62 (1 H, dd, J 14.3, 6.4), 2.40 (1 H, ddd, J 11.3, 8.1, 3.6), 11.92-1.84 (2 H, m), 1.70-1.66 (4 H, m), 
1.55-1.51 (1 H, m), 1.33-1.29 (1 H, m); δC (100 MHz, CDCl3) 157.1, 107.4, 54.9 (CH), 49.1 (Me), 40.5 
(CH), 38.4 (CH), 31.5 (CH2), 31.1 (CH2), 25.4 (CH2), 23.0 (CH2), 20.6 (CH2). 
 
Methyl 5-(cyclohex-1-en-1-yl)-4-(((methoxycarbonyl)thio)methyl)-2-oxooxazole-3(2H)-
carboxylate 17 
 
Potassium hydroxide (0.224 g, 4.0 mmol) was added to a solution of thiazolidinone 11 (0.042 g, 
0.20 mmol) in water (1 mL) and 1,4-dioxane (1 mL). The mixture was stirred at room temperature 
for 30 min, diluted with hydrochloric acid (6 M; 1 mL) and extracted with ethyl acetate (3 x 3 mL). 
The organic phases were washed with brine (5 mL), dried (Na2SO4), filtered and concentrated.  
The residue was dissolved in THF (2 mL), and cooled to 0 °C, then triethylamine (0.04 mL, 0.24 
mmol) and methyl chloroformate (0.08 mL, 1.0 mmol) were added sequentially. The mixture was 
stirred at room temperature for 5 min, diluted with hydrochloric acid (1 M; 2 mL) and extracted 
with ethyl acetate (5 mL). The organic phases was washed with hydrochloric acid (1 M; 3 x 1 mL) 
and brine (2 mL), dried (Na2SO4), filtered and concentrated. Column chromatography eluting with 
ethyl acetate and light petroleum (1:6 to 1:1) gave the title compound as a colorless solid (0.006 g, 
9%); δH (400 MHz; CDCl3) 6.23 (1 H, tt, J 3.8, 1.7), 4.34 (2 H, s), 4.02 (3 H, s), 3.85 (3 H, s), 2.36-2.31 (2 H, 
S H
HHN O
O
OMe
16 
m), 2.27-2.21 (2 H, m), 1.79-1.66 (4 H, m); δC (100 MHz, CDCl3) 170.3, 150.1, 149.5, 140.5, 132.2 (CH), 124.3, 
115.2, 54.8 (Me), 54.5 (Me), 26.3 (CH2), 25.7 (CH2), 25.5 (CH2), 22.0 (CH2), 21.5 (CH2). 
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